Article
Cis-Compound Mutations are Prevalent in Triple Negative Breast Cancer and Can Drive Tumor…
bioRxiv · 2016 · Nao Hiranuma
Key facts
| Title | Cis-Compound Mutations are Prevalent in Triple Negative Breast Cancer and Can Drive Tumor Progression |
|---|---|
| First author | Nao Hiranuma |
| Journal | bioRxiv |
| Published | Nov 5, 2016 |
| DOI | 10.1101/085316 |
| Product codes mentioned | PFT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1